As data becomes everything to everybody, it’s crucial to oversee the quality of information that runs through an organization. When information is ingested by systems analytically and output in ...

The draft guidance provides recommendations for data integrity for clinical and bioanalytical portions of bioavailability and bioequivalence studies submitted with drug applications.

If the data relationships are all captured as constraints in the database (e.g., foreign key constraints), it's a relatively straightforward task to do the integrity checking.